CDK9 anticorps (N-Term)
Aperçu rapide pour CDK9 anticorps (N-Term) (ABIN925994)
Antigène
Voir toutes CDK9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Chien, Souris, Rat (Rattus), Poulet, Poisson zebré (Brachydanio rerio), Boeuf (Vache), Porc, Grenouille
-
Immunogène
- CDK9 antibody was raised in rabbit using the N terminal of CDK9 as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
CDK9 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CDK9 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
-
Autre désignation
- CDK9
-
Sujet
- CDK9 is the member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro. Synonyms: Polyclonal CDK9 antibody, Anti-CDK9 antibody, cyclin-dependent kinase 9, CDC2-related kinase antibody, RP11-228B15.5 antibody, C-2k antibody, CDC2L4 antibody, PITALRE antibody, TAK antibody.
-
Pathways
- Cycle Cellulaire
Antigène
-